|
|
|
|
|
|
|
15.01.26 - 17:01
|
Tuukka Paavola appointed as Chief Financial Officer of Bioretec (PR Newswire)
|
|
|
Bioretec Ltd Company announcement 15 January 2026 at 5:30 p.m. EET TAMPERE, Finland, Jan. 15, 2026 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Tuukka Paavola (M.Sc. Industrial Engineering, CFA) as Chief Financial Officer, effective 20 January 2025.......
|
|
|
|
|
|
|
14.01.26 - 09:36
|
Bayer-Partner Orion mit Top-Prognose – AKTIONÄR-Tipp geht steil (Der Aktionaer)
|
|
|
Nubeqa (Darolutamid) trifft weiterhin auf eine rege Nachfrage. Das Prostatakrebs-Medikament, welches von der finnischen Orion Corporation an das DAX-Unternehmen Bayer vor vielen Jahren auslizenziert wurde, steht vor weiterem, dynamischem Wachstum. Das unterstreicht eine Prognose, die Orion dem Kapitalmarkt am Mittwoch an die Hand gegeben hat....
|
|
|
|
|
13.01.26 - 17:27
|
Faron Pharmaceuticals Ltd: PDMR Dealing (Accesswire)
|
|
|
TURKU, FINLAND / ACCESS Newswire / January 13, 2026 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN), a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, announces ......
|
|
|
|
|
|
|
12.01.26 - 08:01
|
Optomed and Aireen Announce Strategic Partnership and Achieve Approval for AI-Powered Handheld Diabetic Retinopathy Screening (Cision)
|
|
|
Optomed Plc Press Release 12 January 2026 at 9.00, Helsinki
Optomed and Aireen Announce Strategic Partnership and Achieve Approval for AI-Powered Handheld Diabetic Retinopathy Screening
Optomed and Aireen a.s., a pioneer in AI-driven medical diagnostics, today announced a strategic partnership to deliver AI-powered handheld imaging solutions. As part of this collaboration, Optomed's flagship handheld fundus camera, Optomed Lumo®, has been approved for integration with Aireen's AI algorithm for diabetic retinopathy screening in the EU market.
This regulatory milestone enables...
|
|
|
|
|
|
|
|
|
07.01.26 - 12:06
|
Terveystalo acquires Silmäsairaala Pilke Oy and Turun Silmälaser Oy – strengthens position in eye surgery (Cision)
|
|
|
Terveystalo Plc, press release, 7 January 2026
Terveystalo Healthcare Plc signed agreements on 3 December 2025 to acquire all shares in Silmäsairaala Pilke Oy and Turun Silmälaser Oy (collectively “Silmäsairaala Pilke”). The transactions were completed on 31 December 2025.
Silmäsairaala Pilke provides ophthalmology services, eye examinations, and advanced surgical procedures, including cataract, lens, and refractive surgeries, primarily for private customers. In 2024, the companies' combined revenue was approximately EUR 8.2 million. Silmäsairaala Pilke employs around 35 professionals...
|
|
|
|
|
|
|
|
|
23.12.25 - 07:12
|
Inside information: Terveystalo acquires Hohde Group (Cision)
|
|
|
Terveystalo Plc INSIDE INFORMATION 23 December 2025 at 8:00 a.m. EET
Terveystalo Healthcare Oy ("Terveystalo") today, 23 December 2025, signed an agreement to acquire Hohde Group, consisting of Hammas Hohde Oy dental clinics and Loisto Laboratoriot Oy dental laboratories (the "Arrangement"). If completed, the arrangement would strengthen the Terveystalo Group's oral health services for different customer groups. The arrangement is expected to be completed in 2026, subject to the approval of the Finnish Competition and Consumer Authority.
The Enterprise value (EV) of the target,...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
